Humana Inc. Files 2023 Annual Report on Form 10-K

Ticker: HUM · Form: 10-K · Filed: 2024-02-15T00:00:00.000Z

Sentiment: neutral

Topics: 10-K, Annual Report, Humana Inc., Healthcare, Financials

TL;DR

<b>Humana Inc. has filed its 2023 10-K report, detailing its financial performance and operations.</b>

AI Summary

HUMANA INC (HUM) filed a Annual Report (10-K) with the SEC on February 15, 2024. Humana Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2023. The filing was made on February 15, 2024. The company's principal business is in Hospital & Medical Service Plans (SIC 6324). Humana Inc. is incorporated in Delaware. The company's principal executive offices are located at 500 W Main St, Louisville, KY 40202.

Why It Matters

For investors and stakeholders tracking HUMANA INC, this filing contains several important signals. This 10-K filing provides a comprehensive overview of Humana's financial health, operational strategies, and risk factors for the fiscal year 2023, which is crucial for investors to assess the company's performance and future outlook. As a major player in the health insurance industry, Humana's annual report offers insights into market trends, regulatory impacts, and competitive positioning within the healthcare sector.

Risk Assessment

Risk Level: medium — HUMANA INC shows moderate risk based on this filing. The company operates in the highly regulated healthcare industry, facing risks related to government policy changes, reimbursement rates, and compliance requirements, which could materially impact its financial results.

Analyst Insight

Investors should review Humana's detailed financial statements and risk factor disclosures in the 10-K to understand the company's performance and potential challenges in the evolving healthcare landscape.

Key Numbers

Key Players & Entities

FAQ

When did HUMANA INC file this 10-K?

HUMANA INC filed this Annual Report (10-K) with the SEC on February 15, 2024.

What is a 10-K filing?

A 10-K is a comprehensive annual financial report required by the SEC, covering audited financials, business operations, risk factors, and management discussion. This particular 10-K was filed by HUMANA INC (HUM).

Where can I read the original 10-K filing from HUMANA INC?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by HUMANA INC.

What are the key takeaways from HUMANA INC's 10-K?

HUMANA INC filed this 10-K on February 15, 2024. Key takeaways: Humana Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2023.. The filing was made on February 15, 2024.. The company's principal business is in Hospital & Medical Service Plans (SIC 6324)..

Is HUMANA INC a risky investment based on this filing?

Based on this 10-K, HUMANA INC presents a moderate-risk profile. The company operates in the highly regulated healthcare industry, facing risks related to government policy changes, reimbursement rates, and compliance requirements, which could materially impact its financial results.

What should investors do after reading HUMANA INC's 10-K?

Investors should review Humana's detailed financial statements and risk factor disclosures in the 10-K to understand the company's performance and potential challenges in the evolving healthcare landscape. The overall sentiment from this filing is neutral.

How does HUMANA INC compare to its industry peers?

Humana Inc. operates within the health insurance and healthcare services industry, a sector characterized by significant regulatory oversight and evolving market dynamics.

Are there regulatory concerns for HUMANA INC?

The healthcare industry is subject to extensive regulation by federal and state governments, impacting coverage, reimbursement, and operational compliance.

Industry Context

Humana Inc. operates within the health insurance and healthcare services industry, a sector characterized by significant regulatory oversight and evolving market dynamics.

Regulatory Implications

The healthcare industry is subject to extensive regulation by federal and state governments, impacting coverage, reimbursement, and operational compliance.

What Investors Should Do

  1. Review Humana's financial statements for the fiscal year ended December 31, 2023.
  2. Analyze the risk factors section for potential impacts on future performance.
  3. Assess management's discussion and analysis of financial condition and results of operations.

Key Dates

Year-Over-Year Comparison

This filing is the annual 10-K report for the fiscal year 2023, providing updated financial and operational information compared to previous filings.

From the Filing

0000049071-24-000012.txt : 20240215 0000049071-24-000012.hdr.sgml : 20240215 20240215165539 ACCESSION NUMBER: 0000049071-24-000012 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 132 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANA INC CENTRAL INDEX KEY: 0000049071 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 610647538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05975 FILM NUMBER: 24644596 BUSINESS ADDRESS: STREET 1: 500 W MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5025801000 MAIL ADDRESS: STREET 1: 500 W. MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: EXTENDICARE INC DATE OF NAME CHANGE: 19740404 FORMER COMPANY: FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC DATE OF NAME CHANGE: 19671129 10-K 1 hum-20231231.htm 10-K hum-20231231 0000049071 2023 FY false 0.1667 0.1667 http://fasb.org/us-gaap/2023#HealthCareMember http://fasb.org/us-gaap/2023#HealthCareMember http://fasb.org/us-gaap/2023#HealthCareMember http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent P1Y P9Y 0.1667 0.1667 0000049071 2023-01-01 2023-12-31 0000049071 2023-06-30 iso4217:USD 0000049071 2024-01-31 xbrli:shares 0000049071 2023-12-31 0000049071 2022-12-31 iso4217:USD xbrli:shares 0000049071 2022-01-01 2022-12-31 0000049071 2021-01-01 2021-12-31 0000049071 us-gaap:CommonStockMember 2020-12-31 0000049071 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000049071 us-gaap:RetainedEarningsMember 2020-12-31 0000049071 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000049071 us-gaap:TreasuryStockCommonMember 2020-12-31 0000049071 us-gaap:ParentMember 2020-12-31 0000049071 us-gaap:NoncontrollingInterestMember 2020-12-31 0000049071 2020-12-31 0000049071 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000049071 us-gaap:ParentMember 2021-01-01 2021-12-31 0000049071 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0000049071 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0000049071 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000049071 us-gaap:TreasuryStockCommonMember 2021-01-01 2021-12-31 0000049071 us-gaap:CommonStockMember 2021-12-31 0000049071 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000049071 us-gaap:RetainedEarningsMember 2021-12-31 0000049071 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000049071 us-gaap:TreasuryStockCommonMember 2021-12-31 0000049071 us-gaap:ParentMember 2021-12-31 0000049071 us-gaap:NoncontrollingInterestMember 2021-12-31 0000049071 2021-12-31 0000049071 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000049071 us-gaap:ParentMember 2022-01-01 2022-12-31 0000049071 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0000049071 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000049071 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0000049071 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000049071 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000049071 us-gaap:CommonStockMember 2022-12-31 0000049071 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000049071 us-gaap:RetainedEarningsMember 2022-12-31 0000049071 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000049071 us-gaap:TreasuryStockCommonMember 2022-12-31 0000049071 us-gaap:ParentMember 2022-12-31 0000049071 us-gaap:NoncontrollingInterestMember 2022-12-31 0000049071 us-gaap:RetainedEarningsMember 2023-01-01 2023

View on Read The Filing